Major human drug trial underway for Alzheimer's
A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...
Alzheimer's disease & dementia
May 23, 2013 |
not rated yet |
0
Beta-blockers may boost chemo effect in childhood cancer
Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Jo ...
Cancer
May 22, 2013 |
not rated yet |
0
New protein-targeting drug shows promise in early trial for patients with high-risk CLL
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...
Cancer
May 17, 2013 |
not rated yet |
0
|
Australia: Stroke rates decline, but many still preventable
The rate of strokes suffered by Australians has dropped over the past 20 years, while strokes caused by an irregular heartbeat now account for one third of all strokes, according to new research led by the University of Adelaide.
Cardiology
May 16, 2013 |
not rated yet |
0
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other
May 02, 2013 |
not rated yet |
0
FDA warns consumers of dangers of the stimulant DMAA
(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...
Health
Apr 15, 2013 |
5 / 5 (2) |
0
Currently approved drugs found effective in laboratory mice against bioterror threats
In the most extensive screen of its kind, Texas Biomed scientists in San Antonio have demonstrated the feasibility of repurposing already-approved drugs for use against highly pathogenic bacteria and viruses. The pathogens ...
Medical research
Apr 09, 2013 |
not rated yet |
0
|
FDA expands approval of Bayer cancer drug (Update)
The U.S. Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that do not respond to other treatments.
Medications
Feb 25, 2013 |
not rated yet |
0
Potential treatment prevents damage from prolonged seizures
A new type of prophylactic treatment for brain injury following prolonged epileptic seizures has been developed by Emory University School of Medicine investigators.
Neuroscience
Feb 11, 2013 |
not rated yet |
0
|
No proof drugs ease kids' migraines, study says
(HealthDay)—Children and teens who get migraine headaches suffer in multiple ways, missing school and fun time with friends while waiting for the debilitating pain to subside.
Pediatrics
Jan 28, 2013 |
5 / 5 (1) |
0
|
FDA approves 3 new drugs for type 2 diabetes
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Medications
Jan 26, 2013 |
5 / 5 (2) |
1
Black patients with hypertension not prescribed diuretics enough
A research study of more than 600 black patients with uncontrolled hypertension found that less than half were prescribed a diuretic drug with proven benefit that costs just pennies a day, report researchers at Weill Cornell ...
Cardiology
Jan 22, 2013 |
not rated yet |
0
Triple mix of blood pressure drugs and painkillers linked to kidney problems
Patients who take a triple combination of blood pressure drugs and common painkillers are at an increased risk of serious kidney problems, especially at the start of treatment, finds a study published in BMJ today.
Diseases, Conditions, Syndromes
Jan 08, 2013 |
5 / 5 (2) |
0
Can blood pressure drugs reduce the risk of dementia?
People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will ...
Neuroscience
Jan 07, 2013 |
not rated yet |
0
|
Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Medications
Dec 17, 2012 |
not rated yet |
0
